Related references
Note: Only part of the references are listed.AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression
Y. Li et al.
ONCOGENE (2012)
Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1
Changmeng Cai et al.
CANCER CELL (2011)
Intragenic Rearrangement and Altered RNA Splicing of the Androgen Receptor in a Cell-Based Model of Prostate Cancer Progression
Yingming Li et al.
CANCER RESEARCH (2011)
Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants
Elahe A. Mostaghel et al.
CLINICAL CANCER RESEARCH (2011)
Alternatively spliced androgen receptor variants
Scott M. Dehm et al.
ENDOCRINE-RELATED CANCER (2011)
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. De Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival
Emma Hornberg et al.
PLOS ONE (2011)
A Snapshot of the Expression Signature of Androgen Receptor Splicing Variants and Their Distinctive Transcriptional Activities
Rong Hu et al.
PROSTATE (2011)
Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor
Raymond J. Andersen et al.
CANCER CELL (2010)
A (RKLKK633)-R-629 motif in the hinge region controls the androgen receptor at multiple levels
Tamzin M. Tanner et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
Shihua Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
Philip A. Watson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
Zhiyong Guo et al.
CANCER RESEARCH (2009)
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2009)
Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
Qianben Wang et al.
CELL (2009)
Starving the Addiction: New Opportunities for Durable Suppression of AR Signaling in Prostate Cancer
Karen E. Knudsen et al.
CLINICAL CANCER RESEARCH (2009)
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
Scott M. Dehm et al.
CANCER RESEARCH (2008)
Characterization of nuclear import of the domain-specific androgen receptor in association with the importin α/β and Ran-guanosine 5′-triphosphate systems
Natsuko Kaku et al.
ENDOCRINOLOGY (2008)
Structural basis for the nuclear import of the human androgen receptor
Mark L. Cutress et al.
JOURNAL OF CELL SCIENCE (2008)
The intersection of steroid receptors with molecular chaperones: Observations and questions
David F. Smith et al.
MOLECULAR ENDOCRINOLOGY (2008)
The multiple lives of NMD factors: balancing roles in gene and genome regulation
Olaf Isken et al.
NATURE REVIEWS GENETICS (2008)
Androgen receptor structural and functional elements: Role and regulation in prostate cancer
Scott M. Dehm et al.
MOLECULAR ENDOCRINOLOGY (2007)
Selective role of an NH2-Terminal WxxLF motif for aberrant androgen receptor activation in androgen depletion-independent prostate cancer cells
Scott M. Dehm et al.
CANCER RESEARCH (2007)
The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor
Annemie Haelens et al.
CANCER RESEARCH (2007)
Ligand-independent androgen receptor activity is activation function-2-independent and resistant to antiandrogens in androgen refractory prostate cancer cells
Scott M. Dehm et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Defining the requirements for Hsp40 and Hsp70 in the Hsp90 chaperone pathway
Nela S. Cintron et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Lineage dependency and lineage-survival oncogenes in human cancer
Levi A. Garraway et al.
NATURE REVIEWS CANCER (2006)
Interplay between two hormone-independent activation domains in the androgen receptor
L Callewaert et al.
CANCER RESEARCH (2006)
Structural basis of androgen receptor binding to selective androgen response elements
PL Shaffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Intranuclear organization and function of the androgen receptor
BE Black et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2004)
Identification and characterization of a ligand-regulated nuclear export signal in androgen receptor
AJ Saporita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function
MF Fu et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
HSP40 binding is the first step in the HSP90 chaperoning pathway for the progesterone receptor
MP Hernández et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
E2F activity is biphasically regulated by androgens in LNCaP cells
K Hofman et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation
MF Fu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
